The Medicines Company (MDCO: NASDAQ)
$33.64 n/a | n/a%
08/28/15 - 04:00 PM ET
n/a / 1.27MVol / Avg. Vol:
n/a / 31.75Open / Prev. Close:
32.48 - 34.4Today's Range:
19.92 - 34.752 Wk Range:
Portfolios with MDCO
- Portfolio NameUser Type
- ContributorToxic Stocks for the Week E...
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 3
- ContributorStocks At New 52-Week Highs...
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Small Cap...
- Userdarrylb Portfolio 1
- Usermiamirocksters Portfolio 1
- ContributorBarron's Research Reports 4...
- UserPART 3 JPMorgan 27th Annual...
Latest MDCO Headlines from TheStreet
- Today's Weak On High Volume Stock: Medicines Company (MDCO) 07.29.15 | 10:07 am
- Strong On High Relative Volume: Medicines Company (MDCO) 07.06.15 | 10:07 am
- Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling? 07.02.15 | 02:07 pm
- Medicines Company (MDCO) Marked As A Barbarian At The Gate 06.25.15 | 02:06 pm
- Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders 06.11.15 | 11:06 am
- First Week of January 2016 Options Trading For Medicines (MDCO) 05.19.15 | 11:05 am
- Insider Trading Alert - AMP, MDCO And MEMP Traded By Insiders 04.21.15 | 11:04 am
- Medicines Company (MDCO) Weak On High Volume 04.20.15 | 10:04 am
- Medicines Company (MDCO) Strong On High Relative Volume Today 04.13.15 | 10:04 am
- Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours 04.10.15 | 09:04 am
Press Releases for MDCO
- The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results - Business Wire 07.29.15 | 07:07 am
- The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015 - Business Wire 07.13.15 | 07:07 am
- The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin) - Business Wire 07.09.15 | 08:07 am
- Federal Circuit Rules Against The Medicines Company In Angiomax® (bivalirudin) Patent Litigation - Business Wire 07.02.15 | 12:07 pm
- KENGREAL(TM)(cangrelor)(Photo: Business Wire) - Business Wire 06.22.15 | 03:06 pm
- Bios/Backgrounders - Business Wire 06.01.15 | 07:06 am
- The Medicines Company To Hold Conference Call On Tuesday, June 2 To Discuss Clinical Trial Results Of ABP-700 And MDCO-216 - Business Wire 06.01.15 | 07:06 am
- The Medicines Company Presents New Data Showing Remodeling Effect Of MDCO-216 On HDL Particles In Coronary Artery Disease Patients - Business Wire 05.26.15 | 10:05 am
- The Medicines Company To Participate In The Jefferies 2015 Healthcare Conference - Business Wire 05.22.15 | 07:05 am
- The Medicines Company To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference - Business Wire 05.07.15 | 03:05 pm
Partner Headlines for MDCO
- The Medicines Co. upgraded to Buy from Hold at Jefferies - The Fly 08.28.15 | 06:08 am
- The Medicines Co. risk/reward positive, says RBC Capital - The Fly 08.12.15 | 07:08 am
- Alnylam's Q2 Loss Wider than Expected, Revenues Fall Short - Analyst Blog - Zacks 08.07.15 | 05:08 pm
- SkyWest, Medicines Co, Tesla Motors, Keurig Green Mountain and Coca Cola highlighted as Zacks Bull and Bear of the Day - Press Releases - Zacks 08.06.15 | 09:08 am
- Hospira (HSP) Launches Generic Angiomax in the U.S. - Analyst Blog - Zacks 07.17.15 | 04:07 pm
- Will Currency Hit J&J's (JNJ) Second Quarter Earnings? - Analyst Blog - Zacks 07.10.15 | 05:07 pm
- The Medicines Company (MDCO) Jumps: Stock Rises 10.4% - Tale of the Tape - Zacks 07.06.15 | 09:07 am
- The Medicines Co. upgraded to Buy from Neutral at Mizuho - The Fly 07.06.15 | 06:07 am
- Eagle Pharmaceuticals price target raised to $94 from $75 at Piper Jaffray - The Fly 07.06.15 | 06:07 am
- Cantor lowers sales assumptions for Eagle's Angiomax version - The Fly 07.02.15 | 01:07 pm